[HTML][HTML] New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives
M Terreni, M Taccani, M Pregnolato - Molecules, 2021 - mdpi.com
The present work aims to examine the worrying problem of antibiotic resistance and the
emergence of multidrug-resistant bacterial strains, which have now become really common …
emergence of multidrug-resistant bacterial strains, which have now become really common …
Fighting antibiotic resistance—strategies and (pre) clinical developments to find new antibacterials
S Walesch, J Birkelbach, G Jézéquel, FPJ Haeckl… - EMBO …, 2023 - embopress.org
Antibacterial resistance is one of the greatest threats to human health. The development of
new therapeutics against bacterial pathogens has slowed drastically since the approvals of …
new therapeutics against bacterial pathogens has slowed drastically since the approvals of …
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE …
M Bassetti, R Echols, Y Matsunaga… - The Lancet Infectious …, 2021 - thelancet.com
Background New antibiotics are needed for the treatment of patients with life-threatening
carbapenem-resistant Gram-negative infections. We assessed the efficacy and safety of …
carbapenem-resistant Gram-negative infections. We assessed the efficacy and safety of …
[HTML][HTML] Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance
S Karakonstantis, M Rousaki, EI Kritsotakis - Antibiotics, 2022 - mdpi.com
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed
MS Butler, V Gigante, H Sati, S Paulin… - Antimicrobial agents …, 2022 - Am Soc Microbiol
There is an urgent global need for new strategies and drugs to control and treat multidrug-
resistant bacterial infections. In 2017, the World Health Organization (WHO) released a list of …
resistant bacterial infections. In 2017, the World Health Organization (WHO) released a list of …
[HTML][HTML] Microbial resistance movements: an overview of global public health threats posed by antimicrobial resistance, and how best to counter
Antibiotics changed medical practice by significantly decreasing the morbidity and mortality
associated with bacterial infection. However, infectious diseases remain the leading cause …
associated with bacterial infection. However, infectious diseases remain the leading cause …
Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review
M Tilahun, Y Kassa, A Gedefie… - Infection and drug …, 2021 - Taylor & Francis
Infections due to multidrug-resistant Enterobacteriaceae have become major international
public health problem due to the inadequate treatment options and the historically lagged …
public health problem due to the inadequate treatment options and the historically lagged …
The importance of sulfur-containing motifs in drug design and discovery
Introduction Sulfur-containing functional groups are privileged motifs that occur in various
pharmacologically effective substances and several natural products. Various functionalities …
pharmacologically effective substances and several natural products. Various functionalities …
Treatment options for carbapenem-resistant gram-negative bacterial infections
Y Doi - Clinical Infectious Diseases, 2019 - academic.oup.com
Antimicrobial resistance has become one of the greatest threats to public health, with rising
resistance to carbapenems being a particular concern due to the lack of effective and safe …
resistance to carbapenems being a particular concern due to the lack of effective and safe …
In vitro activity of cefiderocol against a broad range of clinically important Gram-negative bacteria
Y Yamano - Clinical Infectious Diseases, 2019 - academic.oup.com
Carbapenem-resistant gram-negative bacteria including Enterobacteriaceae as well as
nonfermenters, such as Pseudomonas aeruginosa and Acinetobacter baumannii, have …
nonfermenters, such as Pseudomonas aeruginosa and Acinetobacter baumannii, have …